Clinical Trial Update: Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) [NA]

View source ↗

Summary

Clinical trial on chloroquine for reducing atheroma in patients with metabolic syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypertension
• Metabolic Syndrome
• Overweight
• Prediabetic State

Drugs mentioned

• Chloroquine (chloroquine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Metabolic Syndrome X, Overweight | NA | Status: COMPLETED | Results posted: 2021-06-25